• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

BioTime Inc.

Started by caliban , Mar 25 2011 01:11 AM
economics regenerative medicine stemells tissue engineering regmed

  • Please log in to reply
777 replies to this topic

#241 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 04 March 2013 - 02:27 PM

BIOTIME, INC. : BioTime and Subsidiary LifeMap Sciences Announce Data ...
4-traders (press release) - 2 hours ago
BioTime, Inc. (NYSE MKT: BTX) and its bioinformatics subsidiary LifeMap Sciences, Inc. ("LifeMap") today announced that they have entered into a definitive collaboration agreement to utilize LifeMap's computer-based tools to extract information ...

View the full article

#242 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 12 March 2013 - 01:09 PM

BIOTIME, INC. : BioTime Appoints Stephen C. Farrell to Board of Directors
4-traders (press release) - 46 minutes ago
BioTime, Inc. (NYSE MKT: BTX) today announced that Stephen C. Farrell has been appointed to its Board of Directors. "We are pleased to welcome an experienced executive of Steve's caliber to BioTime's board," said Alfred D. Kingsley, Chairman of the ...

View the full article

#243 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 13 March 2013 - 01:12 PM

BIOTIME, INC. : BioTime to Present at 25th Annual ROTH Conference
4-traders (press release) - 1 hour ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Dr.

View the full article

sponsored ad

  • Advert

#244 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 13 March 2013 - 01:12 PM

BIOTIME, INC. : BioTime to Present at 25th Annual ROTH Conference
4-traders (press release) - 4 hours ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Dr.

View the full article

#245 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 13 March 2013 - 01:12 PM

BIOTIME, INC. : BioTime to Present at 25th Annual ROTH Conference
4-traders (press release) - 8 hours ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Dr.

View the full article

#246 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 12 March 2013 - 01:09 PM

BIOTIME, INC. : BioTime Appoints Stephen C. Farrell to Board of Directors
4-traders (press release) - Mar 12, 2013
BioTime, Inc. (NYSE MKT: BTX) today announced that Stephen C. Farrell has been appointed to its Board of Directors. "We are pleased to welcome an experienced executive of Steve's caliber to BioTime's board," said Alfred D. Kingsley, Chairman of the ...

View the full article

#247 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 13 March 2013 - 01:12 PM

BIOTIME, INC. : BioTime to Present at 25th Annual ROTH Conference
4-traders (press release) - Mar 13, 2013
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Dr.

View the full article

#248 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 18 March 2013 - 08:56 PM

BIOTIME, INC. : BioTime Announces Fourth Quarter and Fiscal Year End 2012 ...
4-traders (press release) - Mar 18, 2013
03/18/2013| 04:55pm US/Eastern. BioTime, Inc. (NYSE MKT: BTX), today reported financial results for the fourth quarter and year ended December 31, 2012 and highlighted its fourth quarter and recent corporate accomplishments.

View the full article

#249 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 25 March 2013 - 07:00 PM

BIOTIME, INC. : LifeMap Sciences, a Subsidiary of BioTime, Announces Release ...
4-traders (press release) - 11 hours ago
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of LifeMap DiscoveryTM version 1.1 (discovery.

View the full article

#250 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 19 March 2013 - 12:25 AM

BioTime (BTX) Releases Quarterly Earnings Results
Mideast Time - Mar 19, 2013
BioTime, Inc. is a biotechnology company engaged in two areas of biomedical research and product development. Keep up with the latest quarterly earnings announcements by subscribing to our daily earnings update.

View the full article

#251 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 08 March 2013 - 05:09 PM

BioTime and Romulus Agree to Accelerate Closing Date for Second Tranche of ...
PharmaLive (press release) (subscription) - Mar 8, 2013
(BUSINESS WIRE)--Mar 7, 2013 - BioTime, Inc. (NYSE MKT: BTX) today announced it has amended its $5 million Stock and Warrant Purchase Agreement with Romulus Films, Ltd.

View the full article

#252 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 10 April 2013 - 01:17 PM

BIOTIME, INC. : LifeMap Sciences Adds Products Through Partnership with ...
4-traders (press release) - 1 hour ago
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that it is now offering 100 selected ProSpec-Tany TechnoGene (ProSpec) manufactured recombinant proteins related to stem cell research in its recently launched ...

View the full article

#253 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 19 April 2013 - 01:05 PM

BIOTIME, INC. : BioTime Enters into Worldwide License Agreement with UCLA to ...
4-traders (press release) - 2 hours ago
BioTime, Inc. (NYSE MKT: BTX) today announced that it has entered into an exclusive license agreement with the University of California, Los Angeles (UCLA) for novel technology related to the treatment of stroke.

View the full article

#254 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 22 April 2013 - 07:39 AM

BioTime inks pact with UCLA to develop novel technology for treatment of stroke
pharmabiz.com - 2 hours ago
BioTime, Inc.,a biotechnology company focused on regenerative medicine and blood plasma volume expanders, has entered into an exclusive license agreement with the University of California, Los Angeles (UCLA) for novel technology related to the ...

View the full article

#255 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 23 April 2013 - 01:23 PM

BIOTIME, INC. : LifeMap Sciences, a Subsidiary of BioTime, Announces ...
4-traders (press release) - 43 minutes ago
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT:BTX), announced today a collaborative partnership and value-added reseller agreement with Appistry, Inc., which provides big-data computing that supports life-science and medical analytics ...

View the full article

#256 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 24 April 2013 - 03:56 AM

LifeMap Sciences, a Subsidiary of BioTime, Announces Partnership with Appistry
EON: Enhanced Online News (press release) - Apr 24, 2013
BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT:BTX), announced today a collaborative partnership and value-added reseller agreement with Appistry, Inc., which provides big-data computing that supports life-science and ...

View the full article

#257 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 30 April 2013 - 12:33 AM

BIOTIME, INC. : BioTime Announces CFO Succession Plan
4-traders (press release) - 3 hours ago
BioTime, Inc. (NYSE MKT: BTX) announced today that its Senior Vice President and Chief Operating Officer, Robert W. Peabody, will reassume the additional role of Chief Financial Officer on May 10, 2013.

View the full article

#258 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 30 April 2013 - 12:33 AM

BIOTIME, INC. : BioTime Announces CFO Succession Plan
4-traders (press release) - Apr 30, 2013
BioTime, Inc. (NYSE MKT: BTX) announced today that its Senior Vice President and Chief Operating Officer, Robert W. Peabody, will reassume the additional role of Chief Financial Officer on May 10, 2013.

View the full article

#259 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 07 May 2013 - 01:27 PM

BIOTIME, INC. : BioTime and Subsidiary LifeMap Sciences Announce Release ...
4-traders (press release) - 1 hour ago
BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, today announced the release of the enhanced LifeMap BioReagents?
BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced ... - MarketWatch (press release)

View the full article

#260 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 08 May 2013 - 03:49 AM

BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced ...
DailyFinance - 14 hours ago
(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, today announced the release of the enhanced LifeMap BioReagentsâ„¢ portal (http://bioreagents.

View the full article

#261 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 07 May 2013 - 01:44 PM

BIOTIME, INC. : BioTime and Subsidiary LifeMap Sciences Announce Release ...
4-traders (press release) - May 7, 2013
BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, today announced the release of the enhanced LifeMap BioReagents?

View the full article

#262 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 09 May 2013 - 06:31 AM

BioTime, LifeMap Sciences introduce enhanced LifeMap BioReagents portal ...
pharmabiz.com - 2 hours ago
BioTime, Inc., a biotechnology company focused on regenerative medicine and blood plasma volume expanders, and its subsidiary, LifeMap Sciences, have released enhanced LifeMap BioReagents portal (http://bioreagents.

View the full article

#263 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 10 May 2013 - 09:23 PM

BIOTIME, INC. : BioTime Announces First Quarter 2013 Financial Results and ...
4-traders (press release) - 1 hour ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the first quarter ended March 31, 2013 and highlighted recent corporate accomplishments.

View the full article

#264 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 10 May 2013 - 11:21 PM

Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert
Jutia Group - 10 hours ago
We know that former Geron CEO Tom Okarma, who is now part of BioTime Inc. (BTX:NYSE), is in the process of resurrecting the Geron technology as part of a new company.

View the full article

#265 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 14 May 2013 - 02:10 AM

ACT, THRX Hit All-time High, NSPH Makes A Big Move, BTX Gets Funding
NASDAQ - 8 hours ago
BioTime Inc.'s ( BTX ) subsidiary Cell Cure Neurosciences Ltd. has been awarded a grant of approximately $1.5 million from Israel'sOffice of the Chief Scientist for this year to help fund the development of OpRegen.

View the full article

#266 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 14 May 2013 - 11:08 PM

BIOTIME, INC. : BioTime Appoints Franklin Berger to Board of Directors
4-traders (press release) - 1 hour ago
BioTime, Inc. (NYSE MKT: BTX) today announced that Franklin M. Berger, CFA, 63, has been appointed to its Board of Directors.

View the full article

#267 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 13 May 2013 - 02:07 PM

BIOTIME, INC. : BioTime's Subsidiary Cell Cure Neurosciences Ltd. Awarded ...
4-traders (press release) - May 13, 2013
13, 2013-- BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences) today announced that Cell Cure Neurosciences has been awarded a grant of 5.34 million Shekels, approximately $1.5 million, for 2013 ...

View the full article

#268 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 20 May 2013 - 01:15 PM

BIOTIME, INC. : BioTime CEO Dr. Michael West to Present at USC ...
4-traders (press release) - 51 minutes ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the USC Minisymposium: Musculoskeletal ...

View the full article

#269 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 23 May 2013 - 01:16 PM

BIOTIME, INC. : BioTime Announces Results of Vote at Special Meeting of ...
4-traders (press release) - 2 hours ago
Shareholders approve proposals related to the planned acquisition of stem cell assets of Geron Corporation by BioTime subsidiary Asterias Biotherapeutics, Inc. BioTime, Inc. (NYSE MKT: BTX) today announced that at a Special Meeting held on May 21, 2013 ...

View the full article

#270 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 23 May 2013 - 07:27 PM

BIOTIME, INC. : Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure ...
4-traders (press release) - 3 hours ago
BioTime, Inc. : Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support.

View the full article
Back to Ventures & Markets



Also tagged with one or more of these keywords: economics, regenerative medicine, stemells, tissue engineering, regmed

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users

  1. LONGECITY
  2. → Round Table Discussion
  3. → Business
  4. → Ventures & Markets
  5. site rules